509 related articles for article (PubMed ID: 17114654)
1. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and the risk of cancer: a mendelian randomization study.
Allin KH; Nordestgaard BG; Zacho J; Tybjaerg-Hansen A; Bojesen SE
J Natl Cancer Inst; 2010 Feb; 102(3):202-6. PubMed ID: 20056955
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease.
van Durme YM; Verhamme KM; Aarnoudse AJ; Van Pottelberge GR; Hofman A; Witteman JC; Joos GF; Brusselle GG; Stricker BH
Am J Respir Crit Care Med; 2009 Mar; 179(5):375-82. PubMed ID: 19096002
[TBL] [Abstract][Full Text] [Related]
4. Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients--no additional power for mortality prediction with high-sensitivity CRP.
Grootendorst DC; de Jager DJ; Brandenburg VM; Boeschoten EW; Krediet RT; Dekker FW;
Nephrol Dial Transplant; 2007 Nov; 22(11):3277-84. PubMed ID: 17623721
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and risk of breast cancer.
Zhang SM; Lin J; Cook NR; Lee IM; Manson JE; Buring JE; Ridker PM
J Natl Cancer Inst; 2007 Jun; 99(11):890-4. PubMed ID: 17551149
[TBL] [Abstract][Full Text] [Related]
6. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer.
Allin KH; Bojesen SE; Nordestgaard BG
J Clin Oncol; 2009 May; 27(13):2217-24. PubMed ID: 19289618
[TBL] [Abstract][Full Text] [Related]
7. Variation in the C-reactive protein gene is associated with serum levels of CRP in patients with acute ischemic stroke.
den Hertog HM; van den Herik EG; Dippel DW; Koudstaal PJ; de Maat MP
Cerebrovasc Dis; 2010; 29(4):372-5. PubMed ID: 20145391
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Nakatsu T; Saito H; Minamiya Y; Suzuki T; Ogawa J
J Am Coll Surg; 2009 Oct; 209(4):477-83. PubMed ID: 19801321
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses.
Arenillas JF; Massot A; Alvarez-Sabín J; Fernandez-Cadenas I; del Rio-Espinola A; Chacon P; Quintana M; Molina CA; Rovira A; Montaner J
Cerebrovasc Dis; 2009; 28(1):95-102. PubMed ID: 19494488
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms and haplotypes in the C-reactive protein gene and risk of dementia.
van Oijen M; de Maat MP; Kardys I; de Jong FJ; Hofman A; Koudstaal PJ; Witteman JC; Breteler MM
Neurobiol Aging; 2007 Sep; 28(9):1361-6. PubMed ID: 16854501
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
[TBL] [Abstract][Full Text] [Related]
12. Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):690-5. PubMed ID: 16614110
[TBL] [Abstract][Full Text] [Related]
13. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation, C-reactive protein levels, and incidence of diabetes.
Dehghan A; Kardys I; de Maat MP; Uitterlinden AG; Sijbrands EJ; Bootsma AH; Stijnen T; Hofman A; Schram MT; Witteman JC
Diabetes; 2007 Mar; 56(3):872-8. PubMed ID: 17327459
[TBL] [Abstract][Full Text] [Related]
15. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study.
Bos MJ; Schipper CM; Koudstaal PJ; Witteman JC; Hofman A; Breteler MM
Circulation; 2006 Oct; 114(15):1591-8. PubMed ID: 17015791
[TBL] [Abstract][Full Text] [Related]
16. Plasma C-reactive protein and risk of cancer: a prospective study from Greece.
Trichopoulos D; Psaltopoulou T; Orfanos P; Trichopoulou A; Boffetta P
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):381-4. PubMed ID: 16492932
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study.
Kardys I; de Maat MP; Uitterlinden AG; Hofman A; Witteman JC
Eur Heart J; 2006 Jun; 27(11):1331-7. PubMed ID: 16682383
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of combining complement factor H and C-reactive protein genetic profiles for predicting myocardial infarction (from the Rotterdam Study).
Kardys I; de Maat MP; Klaver CC; Despriet DD; Uitterlinden AG; Hofman A; de Jong PT; Witteman JC
Am J Cardiol; 2007 Aug; 100(4):646-8. PubMed ID: 17697822
[TBL] [Abstract][Full Text] [Related]
19. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia.
Rossi E; Hung J; Beilby JP; Knuiman MW; Divitini ML; Bartholomew H
Ann Epidemiol; 2006 Mar; 16(3):206-12. PubMed ID: 16343942
[TBL] [Abstract][Full Text] [Related]
20. Genetic and biochemical markers of obstructive lung disease in the general population.
Dahl M
Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
